NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies gross margin
Gross margin is gross profit as a percentage of revenue.
Neuroone Medical Technologies's gross margin for the twelve months ending Jun 30, 2026 was 55.6%. For fiscal 2025 it was 56.5%, against 31.3% the year before. The highest annual figure on record is 100.0% in fiscal 2010.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 56.5% | +25.2 |
| FY2024 | Sep 30, 2024 | 31.3% | +7.9 |
| FY2023 | Sep 30, 2023 | 23.4% | +64.7 |
| FY2022 | Sep 30, 2022 | -41.4% | +13.5 |
| FY2021 | Sep 30, 2021 | -54.9% | −154.9 |
| FY2013 | Dec 31, 2013 | 100.0% | +0.0 |
| FY2012 | Dec 31, 2012 | 100.0% | +39.6 |
| FY2011 | Dec 31, 2011 | 60.4% | −39.6 |
| FY2010 | Dec 31, 2010 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | 59.9% | +6.0 |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | 53.2% | −2.4 |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | 54.2% | −4.7 |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | 55.8% | +4.0 |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | 53.9% | +19.8 |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | 55.6% | +27.3 |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | 58.9% | +31.6 |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | 51.8% | +25.7 |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | 34.1% | −4.5 |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | 28.3% | +21.6 |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | 27.2% | +38.0 |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | 26.1% | +48.0 |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | 38.7% | +58.7 |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | 6.8% | +105.8 |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -10.7% | +28.1 |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -21.9% | +13.5 |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -20.0% | +34.5 |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -99.0% | +16.8 |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -38.8% | +13.9 |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -35.4% | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -54.5% | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -115.8% | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -52.7% | – |
See a number that looks wrong?